scispace - formally typeset
A

Andrew S J Marshall

Researcher at University of Oxford

Publications -  23
Citations -  2556

Andrew S J Marshall is an academic researcher from University of Oxford. The author has contributed to research in topics: Medicine & Receptor. The author has an hindex of 9, co-authored 13 publications receiving 2241 citations. Previous affiliations of Andrew S J Marshall include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Dectin-1 Mediates the Biological Effects of β-Glucans

TL;DR: It is shown that Dectin-1 mediates the production of TNF-α in response to zymosan and live fungal pathogens, an activity that occurs at the cell surface and requires the cytoplasmic tail and immunoreceptor tyrosine activation motif of Dect in addition to Toll-like receptor (TLR)-2 and Myd88.
Journal ArticleDOI

Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages

TL;DR: Dectin-1, a proinflammatory nonopsonic receptor for beta-glucans, is examined, and it is shown that it mediates the internalization of beta- glucan-bearing ligands, including yeast particles.
Journal ArticleDOI

The human β‐glucan receptor is widely expressed and functionally equivalent to murine Dectin‐1 on primary cells

TL;DR: It is demonstrated that human Dectin‐1, the β‐glucan receptor (βGR), is widely expressed and present on all monocyte populations as well as macrophages, DC, neutrophils and eosinophils, and that this receptor is not myeloid restricted.
Journal ArticleDOI

Structure of the Fungal Beta-Glucan-Binding Immune Receptor Dectin-1: Implications for Function.

TL;DR: Several dectin‐1 crystal structures are reported, including a high‐resolution structure and a 2.8 Å resolution structure in which a short soaked natural β‐glucan is trapped in the crystal lattice, which suggest potential mechanisms of defense against fungal pathogens.
Journal ArticleDOI

Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes

TL;DR: The identification and characterization of a novel myeloid inhibitory C-type lectin-like receptor (MICL) whose expression is primarily restricted to granulocytes and monocytes is reported, suggesting that MICL is a negative regulator of granulocyte and monocyte function.